Skip to content

OIS@SECO

MARCH 4, 2020 | ATLANTA, GA

The “Ophthalmic” Innovation Summit was introduced to facilitate meaningful interactions between ODs, MDs and Industry leaders to accelerate the adoption of innovative non-surgical therapies to address prevalent eye diseases and disorders.

The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

LATEST NEWS

Keeping an "Eye on Innovation" Through News & Analysis

At OIS: Rarities and Thought Provokers

At OIS: Rarities and Thought Provokers

OIS Contributors An eye drop with the potential to fix, albeit temporarily, presbyopia. An artificial endothelial cornea, ready for trial. A neurostimulation device for dry ...
Eyeing Gene Therapy’s Ocular Future

Eyeing Gene Therapy’s Ocular Future

CHICAGO—The first gene therapy approved in the United States happened to be for an inherited eye disease, with an agent that is administered subretinally. But ...
OIS Index Deep in Bear Territory in Q3

OIS Index Deep in Bear Territory in Q3

The OIS Index of ophthalmic stocks posted a miserable Q3 performance, led by the biopharmaceutical stocks in the index. The OIS Index (-12.0%) underperformed the ...
Retina Treatment Beyond Protocol

Retina Treatment Beyond Protocol

CHICAGO — Optimal treatment of retinal diseases hinges on better understanding in three primary areas, said an expert panel at OIS@ASRS 2019: the disease mechanisms ...
What Has 50 Companies, Four Breakout Sessions, Winning Pitch Winners, and a Keynote Conversation? OIS@AAO 2019

What Has 50 Companies, Four Breakout Sessions, Winning Pitch Winners, and a Keynote Conversation? OIS@AAO 2019

SAN FRANCISCO — Winners of a “Shark Tank” style challenge in cataract/refractive and retina and specialty showcase sessions targeting four themes, including gene and cell ...
Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

LensGen CEO Ramgopal Rao says the company has been built around a laser focus on customers’ needs and wants. That led LensGen to identify a ...

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.

Scroll To Top